Atlas Trials

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Clinical trial NCT00847639 · COMPLETED

Trial details

NCT number
NCT00847639
Sponsor
Center for International Blood and Marrow Transplant Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2009-02-01
Primary completion
2013-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.